Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test?

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 8, 2004, Pages 1255-1259

  Renard, Caroline E ^a   Dailly, Eric ^a   Nic Dhonnchadha, Bríd Á ^a   Hascoet, Martine ^a   Bourin, Michel ^a  

^a Lab Physiologie et Pharmacologie   (France)

Author keywords

Antidepressant; Dopamine; Forced swimming test

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; FLUOXETINE; MAPROTILINE; PAROXETINE; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; DRUG EFFECT; FORCED SWIMMING TEST; MALE; MOUSE; NONHUMAN;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; DOPAMINE; FREEZING REACTION, CATALEPTIC; LINEAR MODELS; MALE; MICE; SWIMMING;

EID: 9944248166     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.06.010     Document Type: Article

References (17)

1. M. Bourin, M.C. Colombel, M. Malinge, and J. Bradwejn Clonidine as a sensitising agent in the forced swimming test for revealing antidepressant activity J. Psychiatry Neurosci. 16 1991 199 203
2. M. Bourin, M. Hascoët, B. Mansouri, M.C. Colombel, and J. Bradwejn Comparison of behavioural effects after single and repeated administrations of four benzodiazepines in three mice behavioural models J. Psychiatry Neurosci. 17 1992 72 77
3. M. Bourin, M.C. Colombel, J.P. Redrobe, J. Nizard, M. Hascoët, and G.B. Baker Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages Prog. Neuro-psychopharmacol. Biol. Psychiatry 22 1998 343 351
4. A.S. Brown, and S. Gershon Dopamine and depression J. Neural Transm. Gen. Sect. 9 1993 75 109
5. B.R. Cooper, T.J. Hester, and R.A. Maxwell Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo J. Pharmacol. Exp. Ther. 215 1980 127 134
6. D.J. David, M. Bourin, M. Hascoët, M.C. Colombel, G.B. Baker, and P. Jolliet Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice Psychopharmacology (Berl.) 153 2001 443 449
7. D.J. David, C.E. Renard, P. Jolliet, M. Hascoët, and M. Bourin Antidepressant-like effects in various mice strains in the forced swimming test Psychopharmacology (Berl.) 166 2003 373 382
8. V. Di Matteo, A. De Blasi, C. Di Giulio, and E. Esposito Role of 5-HT(2C) receptors in the control of central dopamine function Trends Pharmacol. Sci. 22 2001 229 232
9. J. Dong, and P. Blier Modification of norepinephrine and serotonin but not dopamine, neuron firing by sustained bupropion treatment Psychopharmacology (Berl.) 155 2001 52 57
10. M. Hascoët, M. Bourin, and S. Khimake Additive effect of lithium and clonidine with 5-HT1A agonists in the forced swimming test Prog. Neuro-psychopharmacol. Biol. Psychiatry 18 1994 381 396
11. J.H. Meyer, V.S. Goulding, A.A. Wilson, D. Hussey, B.K. Christensen, and S. Houle Bupropion occupancy of the dopamine transporter is low during clinical treatment Psychopharmacology (Berl.) 163 2002 102 105
12. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatment Eur. J. Pharmacol. 47 1978 379 391
13. J.P. Redrobe, and M. Bourin Augmentation of antidepressant pharmacotherapy: a preclinical approach using the mouse forced swimming test CNS Spectrum 4 1999 73 81
14. C.E. Renard, E. Dailly, D.J. David, M. Hascoët, and M. Bourin Neurochemical changes following the mouse forced swimming test but not the tail suspension test Fundam. Clin. Pharmacol. 17 2003 449 455
15. H. Takahashi, K. Yoshida, H. Higuchi, T. Shimizu, T. Inoue, and T. Koyama Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reports Clin. Neuropharmacol. 26 2003 230 232
16. M.E. Thase What role do atypical antipsychotic drugs have in treatment-resistant depression? J. Clin. Psychiatry 63 2002 95 103
17. T. Wada, M. Kanno, T. Aoshima, and K. Otani Dose-dependent augmentation effect of bromocriptine in a case with refractory depression Prog. Neuro-psychopharmacol. Biol. Psychiatry 25 2001 457 462